skip to main content
Show Results with:

Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension

Narine, L. et al.

Current medical research and opinion. VOL 21; NUMB 12, ; 2005, 2007-2016 -- LIBRA PHARM LTD (pages 2007-2016) -- 2005

Online access

Notes here allow you and other users to comment and make notes on items, viewable by the whole community.
NB: Please use the Report Catalogue Error form to advise us of catalogue inaccuracies.

Log in to add a note

Tags allow you and others to define and search on related groups of items.

Log in to add / remove tags

Searching Remote Databases, Please Wait